Efficacy of cyclin-dependent kinase 4/6 inhibitors in patients with metastatic hormone positive breast cancer: a single institutional study from India.

Ganguly, Sandip; Mukherjee, Navonil; Mandal, Sayan; Roy, Somnath; Agarwal, Sanjit; Biswas, Bivas; Ghosh, Joydeep

Ganguly, Sandip; Mukherjee, Navonil; Mandal, Sayan; Roy, Somnath; Agarwal, Sanjit; Biswas, Bivas; Ghosh, Joydeep.

Afiliação

Ganguly S; Department of Medical Oncology, Tata Medical Center, 14 Mar EW Arterial Road, Newtown, Kolkata 7000160, India.
Mukherjee N; Department of Medical Oncology, Tata Medical Center, 14 Mar EW Arterial Road, Newtown, Kolkata 7000160, India.
Mandal S; Department of Medical Oncology, Tata Medical Center, 14 Mar EW Arterial Road, Newtown, Kolkata 7000160, India.
Roy S; Department of Medical Oncology, Tata Medical Center, 14 Mar EW Arterial Road, Newtown, Kolkata 7000160, India.
Agarwal S; Department of Breast Surgery, Tata Medical Center, 14 Mar EW Arterial Road, Newtown, Kolkata 7000160, India.
Biswas B; Department of Medical Oncology, Tata Medical Center, 14 Mar EW Arterial Road, Newtown, Kolkata 7000160, India.
Ghosh J; Department of Medical Oncology, Tata Medical Center, 14 Mar EW Arterial Road, Newtown, Kolkata 7000160, India.

Ecancermedicalscience ; 16: 1450, 2022.

Article em En | MEDLINE | ID: mdl-36405937

Palavras-chave

India; breast cancer; palbociclib; ribociclib

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Ecancermedicalscience Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google